TGFB1 and neoplasm: IL-1, TGFβ, and TLR signaling have been shown to converge in TAK1/MAP3K activation, controlling the activation of different transcription factors such as AP-1 and NF-κB, inducing inflammation, proliferation, and chemoresistance in tumor cells [96].